Table 1.
Case report synopsis.
| Avodart 21 March 2018 |
S1 exeresis 15 May 2018 |
Knee S2 S3 1 July 2018 |
S2 exeresis 10 October 2018 |
||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Date | 27 November 2017 | 10 January 2018 | 16 February 2018 | 14 March 2018 | 10 April 2018 | 18 June 2018 | 18 July 2018 | 21 August 2018 | 24 September 2018 | 24 October 2018 | 14 November 2018 | 14 December 2018 | 14 January 2019 | 25 February 2019 | 27 March 2019 |
| PSA ng/ml |
12.76 | 14.07 | 14.32 | 14.79 | 13.04 | 7.50 | 4.93 | 7.12 | 4.86 | 12.09 | 5.67 | 5.41 | 4.82 | 4.21 | 3.37 |
| PSA free/total |
0.12 | 0.12 | 0.12 | 0.11 | 0.16 | 0.13 | ND | 0.22 | 0.17 | 0.10 | ND | 0.18 | 0.15 | 0.16 | 0.18 |
| Prostate MRI |
6 February 2018 | 19 June 2018 | 27 November 2018 |
21
March 2018: Beginning of dutasteride medication.
15
May 2018: First schwannoma resection (S1, right forearm, median nerve).
1
July 2018: Second schwannoma apparition (left knee, double schwannoma S2, S3).
10
October 2018: Second schwannoma resection (S2, common fibular nerve).
MRI, magnetic resonance imaging; PSA, prostate-specific antigen.